Posted inBiotechnology
Boosting antitumor immunity by triggering cancer cell pyroptosis
Gasdermins (GSDMs) are pore-forming executioners of pyroptosis, a highly inflammatory form of programmed cell death that culminates in membrane rupture.…
Posted inBiotechnology
Pusan National University Scientists Create Smart Adaptive Vibration Isolator System
A new kind of vibration “cushion” could soon make precision machinery far more tolerant to real-world changes in load. In…
Posted inBiotechnology
RA Capital launches rare disease company Oak Hill Bio onto Nasdaq via SPAC
Rare disease biotech Oak Hill is headed to the Nasdaq through a SPAC merger with RA Capital-sponsored Research Alliance Corporation…
Posted inBiotechnology
Apnimed aspires for up to $160M IPO as sleep apnea pill launch nears
Apnimed has detailed its plans for an initial public offering, with the biotech intending to raise as much as $160…
Posted inBiotechnology
MapLight shares sink on mixed phase 2 schizophrenia readout
MapLight Therapeutics’ stock plummeted more than 60% this morning after the neuro outfit dropped mixed results for a phase 2…
Posted inMedical Technology
FDA approves Freenome colorectal cancer blood test to be marketed by Abbott
The FDA has approved Freenome’s new blood-based colorectal cancer test, SimpleScreen CRC, which Abbott will exclusively market in the U.S.
Posted inBiotechnology
Sericin directs silk fibroin assembly into ordered nanofibrils, study finds
For thousands of years, silk has been prized for its remarkable strength, luster, and versatility—yet the biochemical choreography that converts…
Posted inBiotechnology
High-Throughput Chip Delivers Full-Frequency Encoded Illumination Super-Resolution Imaging
A new study introduces a high-throughput super-resolution imaging chip that packs advanced microscopy into a compact, on-chip platform. The work,…
Posted inBiotechnology
AI Redesigns Starting Conditions to Improve Protein Evolution Outcomes
AI-designed protein redesigns are shown to reshape the rules of evolution in a new Nature study, offering a “boosted starting…
Posted inBiotechnology
InnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test
InnoCare Pharma announced Monday that its oral tyrosine kinase 2 (TYK2) inhibitor fadeucravacitinib met the primary endpoint in a phase…